Pharmaceutical and Cosmetics manufacturing ADELCO is one of the oldest and most respected pharmaceutical company in Greece , established in 1934 for the manufacture of pharmaceuticals and toiletry cosmetics. The company produces annually about two million pcs of about fifty pharmaceutical items, branded generics and unique combinations in a variety of forms Tablets, Syrups, Creams, capsules etc, with emphasis on Neurological and Cardiological preparations and Folic Acid. Many of which are leaders in the market. The company is located on its own modern private production facilities of about 10.000 m2 supervised in accordance to European GMP
ADL Bionatur Solutions is a holding company integrated by ADL BioPharma and Bionaturis. This new entity arises as a global bioscience corporate group, delivering cost-effective and suitable solutions in health, nutrition, cosmetics and chemicals. The synergy of the integrated companies' competitiveness with complementary strengths have allowed the group to become a major benchmark in biotech and pharmaceutical industries, both in terms of quality and innovation.We are engaged in research, development, manufacturing and commercialization of high-quality and innovative products with unique attributes, making us the perfect partner to meet the changing needs of the market.ADL Bionatur Solutions is listed on MAB Spain.
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI's team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We've got it down to an exact science. We care about the quality and success of your projects as if they were our own. No matter the size of your project or the complexity of the challenge, our experts pinpoint and execute the precise solution to hit your target. From molecule to molecule, batch to batch, your product will benefit from our ingenuity.
has been an independent sourcing partner for the global pharmaceutical industry
for almost 40 years. We manage supply-, financial- and regulatory risk for our
clients and provide stock of more than 150 APIs in our warehouse in Hamburg,
Germany. We naturally follow GDP guidelines and look forward to keeping on solving
the industries challenges together with our partners.
ANFARM SA, a dynamic manufacturer of quality generics since 1967,
promotes its own products worldwide and acts as a third party
manufacturer for multinational companies.
- Lyophilized & Sterile products
- Cephalosporins & Carbapenems
- Non-Sterile Products
Athena aspires to be a global leader in specialty pharma, innovation and drug delivery. It aspires to be a partner of choice for multinational pharmaceutical companies for their life cycle management requirement for mature products with a mission to enhance value to patients & improve compliance which is critical for treatment.
BASF creates chemistry for a sustainable future offering intelligent solutions to the pharmaceutical industry. With its expertise in polymer chemistry, R&D-capabilities and its commitment in developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Soft-Gels, Skin-Delivery and Biologics. BASF offers high quality raw materials for state of the art production of API's. The comprehensive portfolio includes solvents, building blocks, reagents and protective groups. The Catalysts-portfolio includes fine-chemical-catalysts and a full loop of metals-management-services. With its human nutrition solutions, BASF offers a broad portfolio for consumers' needs, including vitamins, carotenoids, plant-sterols, emulsifiers and omega-3.
BIOCAD is a vertically integrated biopharmaceutical company which excels at full-cycle drug discovery and development, as well as commercial-scale manufacturing of biological and chemical therapeutics for the treatment of cancer and autoimmune disorders. BIOCAD's advanced MabNext program is focused on the development of monoclonal antibodies without non-human sequences with high specific activity. The company also has several high-quality mAb biosimilars on the world market.
Bluepharma is a Portuguese pharmaceutical company resulting from the acquisition of Bayer's former plant in 2001.
Through the entrepreneurship of its promoters, Bluepharma Group currently comprises more than 17 innovative affiliates that cover all stages of the pharmaceutical industry value chain.
Bluepharma's R&D-based strategy allowed to target the most demanding markets of over 40 worldwide territories, representing more than 100 clients and an export rate of 85%.
Bluepharma is FDA approved for the development of solid pharmaceutical forms since 2009, becoming the first Portuguese pharmaceutical company to export to the US market.
Bluepharma offers an integrated approach, from R&D to manufacturing and commercialization of medicines. This is achieved through expertise in formulation, analytical development and scale-up of solid dosage forms as well as through the design of novel platforms (e.g. oral this films and complex injectables) along with dedicated facilities for high potency drugs.This has proven to be determinant in our differatiation and competitiveness.
We aim to create value through innovation.
Established in 1996, Capot Chemical Co Ltd is a custom synthesis manufacturer, headquartered in Hangzhou, P.R.China. As an ISO 9001:2008 certificated company, Capot has a safety management system in place. It produces a wide range of organics, especially fluorine, boronic acids, unnatural amino acids, cross linkers, chiral building blocks, heterocyclic compounds and other active pharmaceutical ingredients. Capot has established a global network of customers from many research centers, pharmaceutical companies and chemical factories.
Capot has experienced experts, excellent manufacturing equipment, and a advanced R&D center. It owns the ability to provide products from a few grams to kilograms, even to tons. And it also provides custom synthesis service, to help its customer with its best efforts.
In capot, we care about the quality and success of our customers' projects as if they were our own. We are committed into providing the reliable quality, competitive prices and superior service to our customers.
Centurion Pharma is a Turkish Company located in Istanbul and began its journey in 1949. The core business is importing, developing and manufacturing products directed towards use in treatment of chronical and rarely encountered diseases. The product portfolio range consists of:- Biological plasma products -Biosimilar products -Hospital products -Vaccines. Centurion Pharma, which believes that every patient deserves modern treatment alternatives and high quality of life, invested in special R&D projects in the last 5 years, and it has taken a giant step for specific and special products to be manufactured in Turkey. Centurion Pharma embraces respect for both Humans and Nature.
CordenPharma is your full-service Contract Development & Manufacturing Organization (CDMO) partner for global supply of APIs, Drug Products and Packaging services. Through a network of fully-inspected cGMP facilities across Europe and the US organized under five technology platforms – Peptides, Lipids, & Carbohydrates, Injectables, Highly Potent & Oncology, Small Molecules, and Antibiotics - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.
CPC specializes in the distribution of APIs, biochemical intermediates, food
additives and feed ingredients from recognized international partners. We
follow GDP guidelines, are HACCP & FamiQS certified and registered for
trading intermediates of animal origin. Assistance in logistics, finance and
regulatory affairs is part of our service.
ESSETI FARMACEUTICI is an Italian pharmaceutical company that from its beginning in 1956 has invested in the internationalization process anticipating times on competition, tracing new paths in the export of Italian production, a best banner in the world capable of transmitting and ensuring high quality standards and competitive prices in many markets. The products of our therapeutic areas combine top quality active ingredients made in Europe with innovative and excellence of the manufacturing process. The concept that characterizes the philosophy of our company is orientation to results, dynamism, innovation and attention to the international market.
Evonik Industries provides solutions to the pharmaceutical and biopharmaceutical industry for tomorrow's needs in drug development, manufacturing and drug delivery. As a leading speciality chemicals manufacturer, it offers the broadest portfolio of know-how, products and services available in the market: From biotechnology based products to custom intermediates, from excipients for drug formulations to drug delivery technologies, we provide expertise, service and technology that create competitive advantages for our customers. For customers manufacturing APIs and intermediates Evonik is a globally leading supplier of heterogeneous catalysts as well as homogeneous metathesis catalysts which all can be tailored to customer needs.
Frey + Lau is a leading manufacturer of essential oils under GMP conditions. Our in-house rectification processes are qualified according to latest GMP standards. Our premium API qualities of various essential oils eg. Eucalyptus oil, Peppermint oil and Turpentine oil are under the top 10 oils used in pharmaceutical industry. We support MA-procedures all over the world by full ASMF procedure and ICH stability studies.
A family business, established in 1923, now a multinational OTC pharmaceutical company based in Athens Greece, operating in the local market and globally. With an extensive international footprint, Gerolymatos International is focused on the expansion of its international operations, having already established a presence in numerous key markets through a wide network of affiliated companies, joint ventures and local distributors.
Gerolymatos International is a prominent global player in the field of seawater-based products for nasal care and well positioned in the hair-care & anti-hair loss category. The company is also highly active in contract manufacturing for nasal seawater-based products.
In the Greek local market Gerolymatos International is active in the OTC, Optics, Veterinary fields promoting the company's own brands and well-known international brands.
As one of Europe's most innovative and dynamic businesses, Gerolymatos International was listed in the London Stock Exchange Group's 1000 companies to inspire Europe in 2016, setting an example of leadership, hard work and entrepreneurship within the healthcare/pharma industry.
GM Pharmaceuticals is the leading pharmaceutical manufacturer throughout the Caucasus region where a full production cycle of manufacturing is carried out by means of state-of-the-art technologies, in compliance with PIC/S GMP requirements; About the CompanyFactory is located in the suburbs of Tbilisi in settlement Phonichala;Today GM Pharmaceuticals employs over 500 professionals, making more than 200 pharmaceutical products for a wide range of therapeutic category. Since 2014 GM Pharmaceuticals is awarded GMP PIC/S (Ukraine) certificate which proves the conformity of company quality management system with international standards. Company permanently is audited by GMP independent auditors fromUK and proves the conformity with GMP EU regulations; Company is diversified into several directions: its own production, contract manufacturing, marketing, export and distribution in Georgia and throughout CIS countries
Grünenthal PRO is your Contract Manufacturing partner of choice if you require: a reliable and sustainable strategic Partner; an integrated service provider from API to various packaged forms; a truly global supplier serving ~100 countries in the world; established FMD serialization, EU or any other serialization/aggregation; biopharma assembly, labeling, packaging in cold-chain and release; high expertise in scheduled drug production and handling; hormone production in- or outside of Latin America; experience in hot-melt extrusion or in galenic and analytical development; approvals by FDA, EMA, ANVISA, PMDA and various other national authorities, visit us at our booth 8.0H40!
Established in 2002, Hangzhou FST Pharmaceutical is a private-owned company which is dedicated to R&D and production of advanced intermediates and fine chemicals for pharmaceutical and nutraceuticals.
The main product lines are cardiovascular products,gastro-intestinal products and weight control products. The factory is located in Jiande Hangzhou where is about 250km from
Shanghai, the factory is in compliance with GMP guidance, and is certified with ISO9001:2000 and ISO14001, OHSAS18001.
Located in Changsha National Bio-medical Park, Hunan Jiudian Pharmaceutical Co Ltd is a modern pharmaceutical enterprise specializing in R&D, manufacturing and trading. Jiudian has been awarded as “National High-tech Industrialization Demonstration Project Enterprise”, “National Industrial Technology Advancement Project Enterprise”, “Hunan New & High-tech Enterprise”, “Hunan Excellent Technology Innovation Enterprise”, “Hunan Top-Ten Pharmaceutical Enterprise”. “Jiudian” has been recognized as a famous trademark in Hunan province.
With more than 400 employees, Jiudian occupies approximately a land area of 40,000 square meters and possesses state-of-the-art production facilities GMP-certified by SFDA for active pharmaceutical ingredients (APIs), pharmaceutical adjuvants, solid and liquid oral preparations. The company has established an effective quality management system.
We produce over one hundred products including APIs, pharmaceutical adjuvants, tablets, capsules, granules, oral solutions, syrups, soft extracts, mixtures, cataplasms and injections. We are the sole manufacturer in China for APIs dirithromycin, levodropropizine and levocetirizine hydrochloride. With a mission of “better products, healthier life”, the company commits to the process innovation and product industrialization.
We look forward to building a win-win partnership with our customers.
ILKO is a subsidiary of Selcuklu Holding which has strong institutions across various economic sectors.ILKO was founded by pharmacist Mustafa Öncel who was active in the pharmaceutical industry since 1973, resulting with successful sale of the previous pharma company to international partnerships, in 2006. Öncel family has invested again in pharmaceutical industry with their 40 years experience by young company, ILKO. The company has it's headquarter in ?stanbul, and R&D center in Hacettepe University, Ankara. ILKO has started its business activities in 2012. As of 2018, ILKO has over 600 employees with its own licensed 63 products within 147different forms in different therapeutic areas like; Central Nervous system, Respiratory System, Alimentary and Metabolism, Anti-infectives, Musco-Skeletal System, Cardiovascular System, Genitourinary System, Haematology, Endocrinology & Metabolism and Dermatologicals. ILKO has been approved for EU-GMP certificate by MHRA in the first quarter of 2014 and exports to more than 15 countries already. The production facility of the company is the largest pharmaceutical manufacturing investment in Anatolia. The production complex is located on a 250.000 m2 land and current closed area of the plant is 25.000 m2. The capacity of the plant has been planned for 120 million units per year covering production of different pharmaceutical forms. The current capacity of the first phase investment finalized in 2011 is 25 million units per year, on one shift. ILKO aims to offer innovative products that extend and save lives, as well as add value to the pharmaceutical industry. ILKO Research and Development Center located in Ankara Hacettepe University Technopark is a pioneer pharma research and development center within a University Organization in the country. ILKO R&D Biotechnology Center is located in Istanbul Technopark and has started its activies in 2015. Besides the value added conventional products, developing next generation biobetter and biosimilar products, novel biopharmaceuticals are in the main scope of the company. ILKOGEN is the biopharmaceutical company of ILKO. This joint venture company, ILKOGEN, has been established with one of the leading South Korean biotechnology research company Genexine Inc. in December 2013. A Biobetter product is being developed and Phase II studies are still on going. Business strategy of ILKO is being a global pharmaceutical company by expanding its activities with next generation R&D activities as well as by developing strong business co-operations in; import, export, in and out licensing, and Co-development. In 2016, ILKO has created the brand of Wellcare just about to give a different impulse to Healthcare area with its strong background in pharma industry on the basis of new and ever-changing demands of today, with the target of creating a global brand. Wellcare has products within 6 different categories including; Infant Health, Digestion, Probiotics, Allergy, Vitamins and Minerals, Cough and Cold. Wellcare targets to enhance life quality, provide solutions for health problems in each stage of lifecycle from birth with its innovative, clinical effectiveness' proven, scientific and trustable subsidiary treatment products approved by health authorities.
Kopran Ltd is international pharmaceutical marketing and manufacturing company. We have two WHO GMP approved factories. Our facility at Khopoli for FDF's is approved by TGA, MHRA and MCC and our API facility at Mahad is WHO GMP accredited. We export to major markets in Europe, SE Asia and Latin America.
LABOCHEM SA has been established in 1990 as an agency and distribution company of APIs and excipients for the pharmaceutical, cosmetic and chemical industry, with headquarters in Athens, Greece. Our business activities have expanded all over the world in EU and CIS countries. Labochem develops generic products/dossiers available for exports and license out. We are also agents of machinery (processing and packaging) for the pharma, chemical, cosmetic, personal care and food industries.
Laboserve is an independent, international pharmaceutical company with its own, brand new manufacturing site, headquartered in Athens, Greece. Our purpose-built Liquids Center is supported by in-house QC laboratory, robust quality systems and a team of specialists. It's this combination of expertise and infrastructure that makes Laboserve your preferred partner for liquid products development and manufacturing utilizing controlled substances. We offer licensing rights and optimized supply agreements for differentiated, tailor-made added value generic products. Amongst other, a proprietary pain management portfolio addressing moderate to severe pain is available as unique presentations and drug combinations. We integrate contract pharmaceutical manufacturing solutions with drug development capabilities to streamline your pathway from the laboratory to the market. Our scientists pair decades of pharmaceutical development expertise with leading-edge technologies to assess, identify and implement the right solutions and help discover added value. We provide applied pharmaceutical research and development services, focused on liquid dosage forms. Laboserve goes beyond the expected, offering accompanying manufacturing capabilities and guidance backed by expertise in product development, technical transfers and scale-up.
Milsing is Croatia-based company specialised in the development of healthcare products. Working on the research, development, distribution, marketing and sales, Milsing creates value for its customers and partners worldwide by introducing innovative, premium-quality products, backed by science. Our specialty are innovative dosage formats – chocolate supplements and soft chews. www.chocowise.com
Softigel® by Procaps is a leading provider of Contract Development and Manufacturing services in softgel advanced technologies for the global pharmaceutical and nutraceutical industry. Through our extensive capabilities and deep expertise in product development and softgel manufacturing, we help different companies bring innovative products to their markets faster, offering their patients and consumers an exceptional experience, high preference and superior adherence to different therapies. Our advanced delivery technologies, including Softgel and related technologies, our proven formulation, manufacturing and regulatory expertise, has enabled us to become an integrated CDMO (iCDMO), giving customers full-service, turnkey solutions in prescription drugs, OTC and dietary supplements across both development and delivery. Our differentiating strengths enable us to move into more difficult-to-produce compounds, formulations, dosage forms, and non-traditional manufacturing processes where few competitors can follow. Our Company is infused with a strong belief in the growing need for precisely the sort of generic drugs, specialty Pharma products, and advanced delivery technologies positioned in our pipeline, so developing long-term partnerships based on these breakthrough technologies is our state of mind.
Qatar Pharma is the first intravenous infusion facility in Doha, Qatar which started operating in the year 2009. It has a promising provision of high quality medicinal products in the health care sector. Qatar Pharma is owned and operated by Dr. Ahmed Mohammed Al Sulaiti. Qatar Pharma is the leader in infusion therapy and clinical nutrition in the Gulf. Qatar Pharma produces quality products applying cGMP. It is manufacturing intravenous solutions and other pharmaceutical dosage forms such as small volume parenteral, eye drops, minims, haemodialysis concentrate solutions and topical drugs such as creams, lotions and ointments.
Sharon Bio-Medicine Limited, India established 1989, is a Contract Manufacturer of generic and branded products for companies across the globe. Initially being a manufacturer of Intermediates & APIs for semi-regulated markets, Sharon now provides integrated solutions through its Contract Research and Manufacturing Services (CRAMS) Model for Intermediates, APIs and Finished Dosage Forms. Sharon has set up a state-of-the-art manufacturing facility for Oral Solid Dosage Forms spread over an area of 100000 sq. feet. The plant has capability to manufacture Aqueous, Non-aqueous and temperature/humidity sensitive Tablets & Capsules. At Sharon, we believe in building enduring relationships with our business partners.
Sinochem Jiangsu Co Ltd (Sinochem Jiangsu), established in 1978 with a registered capital of 102 million RM, is one of the key subsidiaries of "Fortune 500" Sinochem Corporation. Sinochem Jiangsu is mainly engaged in the international trade, domestic distribution, R&D, manufacturing and storage of pharmaceutical intermediates, APIs, formulations and other pharmaceutical products. Our clients are widely based in the five continents with annual sales reaching over 200 million dollars.
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), is a leading pharmaceutical development and manufacturing capability and technology platform company serving the life science industry, with operations in China and the United States. As a premier Contract Development and Manufacturing Organization (CDMO), WuXi STA offers our worldwide partners efficient, flexible and high-quality solutions for Active Pharmaceutical Ingredients (APIs) and finished dosage forms.
SUANFARMA Group was born in Spain in 1993 and is specialized in the development, production and marketing of raw materials and finished dosage forms for the pharmaceutical, biotechnological, veterinary, nutritional and cosmetic sectors. International expansion began immediately following the creation of SUANFARMA, so that by 1994 the first commercial office abroad was opened in China. Subsequently, other international subsidiaries were established in different countries. Currently, Suanfarma´s international activities extend to more than 70 countries on all 5 continents. Through a powerful worldwide network we can provide high quality solutions for each individual client's needs.
Founded in 1995, Substipharm is a privately held pharmaceutical company based in Paris, France. It develops, registers and licences out or markets itself generics, branded and OTC pharmaceuticals, in more than 60 countries worldwide. Substipharm specialises in niche and differentiating products, based on technology, market and difficulty.
Symed Labs Ltd is a leading Hyderabad based manufacturer of Active Pharmaceutical Ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemistry related services.
We developed processes for over 50 APIs across various therapeutic categories in the laboratory and scaled them up to plant scale, besides selling them to over 600 customers in 30 countries (since the last decade)including the regulated markets.
Since 1997, Symed Labs has been offering Manufacturing services. Symed's customers include large MNC's, mid-sized pharmaceutical companies; stand-alone Service organizations as well as large Generic companies.
Taiwan Pharmaceutical Alliance (TPA) comprises several Taiwan-based manufacturers, including API & FDF (chemicals & biologics). TPA facilities pass PIC/S GMP. Products are marketed in US, EU, Japan & ASEAN etc. TPA provides quality products with affordable price. Niche products include liposome & microsphere, OROS Tablets/ ODT, high potent soft gel, MDI/DPI, eye drops, patch, biosimilar etc. Services include CDMO/CMO, license in/out, and trading etc. TPA is your trustworthy partner in the dynamic markets.
Vefa Ilaç (Pharmaceuticals) is specialized in the research, development and manufacturing of food supplements & cosmetic products. We have one of the best in class WHO GMP & ISO certified manufacturing capabilities in Euroasia / Turkey. We excel in quality products for human health & well-being.
Polpharma Group is a high quality European pharma and biotech manufacturer and a reputable business partner for pharmaceutical companies worldwide. We grow our presence through B2B activities, including API custom development and manufacturing in our cGMP-compliant and FDA-approved facility, out-licensing of vertically integrated solutions from API to finished formulation, and contract manufacturing services covering a wide variety of solid and liquid forms.
We are also a fully integrated, state-of-the-art
biotechnology CDMO player mastering all steps of the industrial value chain
from cell line generation via process and product development to
biopharmaceutical GMP manufacturing from clinical to commercial scale.